Discover how you can leverage custom R-coding in your oncology study designs!

In today’s rapidly evolving field of oncology research, the complexity and challenges of clinical trial design are increasing day by day. To ensure the success of research, precise and efficient trial design is crucial. This upcoming webinar will offer an in-depth discussion on how to leverage the integration of East Horizon with custom R code to evaluate various analytical options in oncology study design.

East Horizon™ is Cytel’s latest innovative solution that consolidating industry-leading products and allowing the integration of open-source code. The fusion of East Horizon™ and R code not only enhances the user experience but also opens new avenues for introducing innovative types of analyses.

Key Topic

In this 4th edition of our series, Kyle Wathen and Valeria Mazzanti will look at examples of varying analysis types using custom R code in combination with the East Horizon Platform.

Speakers

Kyle Wathen

Vice President, Scientific Strategy and Innovation

Kyle brings experience from a diverse background in academia, consulting, and the life sciences industry to his role at Cytel. Working on the development and application of novel Bayesian methodology for adaptive clinical trial designs, he is involved in each step of developing new adaptive clinical trial designs, starting from initial concept development through software development/trial simulation and completing with trial conduct and data collection.

Kyle has over 20 years of experience in the design of innovative clinical trials such as ​​Bayesian approaches, ​​platform trials and other ​​adaptive approaches. He has been involved in many innovative clinical trials, especially platform trials, in various disease areas including ​oncology, neuroscience, infectious diseases, cardiovascular and inflammation. Additionally, he has released several software packages including OCTOPUS, an R package for simulation of platform trials.

Kyle received his M.S. in statistics from Texas A&M University and M.S. and Ph.D. in Biostatistics from the University of Texas: Graduate School of Biomedical Sciences.

Valeria Mazzanti

Biostatistician and Associate Director of Customer Success

Valeria Mazzanti is Associate Director of Customer Success at Cytel. She is an expert in adaptive clinical trial design methodology and an expert in Cytel software, including cutting-edge and industry standards such as Solara, East and EnForeSys. Prior to joining Cytel, Valeria worked in several different academic research labs, and has extensive teaching experience at prestigious Universities. Valeria completed a Master of Public Health degree specialized in Biostatistics at Columbia University in New York and a Bachelor of Science degree in Behavioral Neuroscience at UCLA.